EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Conditions:   Type 2 Diabetes;   Obesity Interventions:   Other: Weight Management Program (WMP);   Other: Traditional care;   Drug: Phentermine / Topiramate Extended Release Oral Capsule;   Drug: naltrexone/bupropion extended-release;   Drug: liraglutide 3.0 mg;   Drug: Orlistat Sponsor:   The Cleveland Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
Condition:   Obesity Interventions:   Drug: Phentermine-Topiramate Extended Release;   Drug: Placebo;   Other: Online support system Sponsor:   Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2020 Category: Research Source Type: clinical trials